Mr. Favro’s practice is focused on securities litigation, complex business disputes, and government investigations.
Mr. Favro has extensive experience representing clients in federal securities actions, as well as related shareholder derivative lawsuits in state and federal court. In addition to his securities litigation practice, Mr. Favro has represented clients in a broad range of state and federal civil litigation matters, including mass tort claims, breach of contract actions, complex fraud litigation, and trademark disputes. Mr. Favro also has experience in litigating complex cases in international arbitration disputes.
In Mr. Favro’s government investigations and white collar defense practice, he has represented clients in investigations being conducted by the Securities & Exchange Commission, the Food & Drug Administration, the Commodity Futures Trading Commission, and the Department of Justice, particularly in investigations concerning medical device misbranding and off-label marketing.
Mr. Favro earned his J.D., cum laude, from New York University School of Law, where he was a Robert McKay Scholar and served as an executive editor of the New York University Law Review. While in law school, Mr. Favro was a Lederman Milbank Fellow in Law & Economics and the recipient of the Law & Economics prize. Mr. Favro also worked at the U.S. Securities and Exchange Commission as a Summer Honors Legal Intern and at the U.S. Attorney’s Office for the Southern District of New York, Criminal Division. He earned his A.B. in Public Policy & American Institutions and Political Science from Brown University, where he was a member of the Men’s Division I ice hockey team.
Prior to joining Bird Marella in 2018, Mr. Favro was a litigation association at Hueston Hennigan LLP.
Representative Civil Matters
Achieved a complete defense verdict on behalf of one of the world’s largest chip manufacturers after a three-week jury trial in a $175-million breach of contract lawsuit.
Represented publicly-traded pharmaceutical company in Rule 14e-3 national class action litigation concerning alleged insider trading.
Represented publicly-traded pharmaceutical company in national Rule 10b-5 securities class action following remand by the U.S. Supreme Court concerning allegations of off-label marketing and drug safety.
Represented publicly-traded pharmaceutical company in state and federal shareholder derivative lawsuits resulting in multiple dismissals.
Represented an investor-owned utility company in litigation arising from one of the largest wildfires in California’s history.
Represented publicly-traded health food store in Proposition 65 appeal before the California Court of Appeal concerning the applicability of the catalyst theory to an award of attorneys’ fees.
Represented CEO of technology start-up in multi-million dollar arbitration concerning breach of contract, breach of fiduciary duties, and related business torts.
Represented publicly-traded national retailer in trademark dispute and obtained dismissal of plaintiff’s claims at summary judgment.
Representative Investigation and White Collar Matters
Represented publicly-traded company in a federal criminal investigation into alleged violations of the Food, Drug & Cosmetic Act resulting in letter of declination from the U.S. Attorney’s Office.
Obtained declination of prosecution of CEO of a publicly-traded company in a federal criminal investigation into alleged violations of the Food, Drug & Cosmetic Act and related securities fraud allegations.
Represented former banker in multi-agency investigation into U.S. Treasury bond trading.
News & Events
A Bird Marella trial team led by principals Ekwan Rhow and Timothy Yoo prevailed in a federal jury trial before Judge Richard A. Jones in the U.S. District Court for the Western District of Washington in Seattle. Defending SK Hynix America, Inc., one of the largest memory and semiconductor chip manufacturers ...